![Transparency Market Researchが調査・発行した産業分析レポートです。非侵襲的脳刺激装置の世界市場2022-2031：産業分析、規模、シェア、成長、動向、予測 / Non-invasive Brain Stimulation System Market (Product Type: Transcranial Magnetic Stimulation [TMS] System and Transcranial Current Stimulation [TCS] System) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2301F0074資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-70.gif) | • レポートコード：MRC2301F0074 • 出版社/出版日：Transparency Market Research / 2022年10月20日 • レポート形態：英文、PDF、180ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トランスペアレンシー・マーケット・リサーチ社の当調査資料では、世界の非侵襲的脳刺激装置市場について総合的に調査・分析を行い、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場の見通し、製品タイプ別（経頭蓋磁気刺激(TMS)装置、経頭蓋電流刺激(TCS)装置）分析、用途別（うつ病、てんかん、パーキンソン病、慢性疼痛、その他）分析、エンドユーザー別（病院、外来手術センター、専門クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、Brainbox Ltd.、BrainsWay、eNeura, Inc.、Flow Neuroscience、Magnus Medical, Inc.、Magstim、MagVenture、NeoSync, Inc. (Wave Neuroscience, Inc.)、NeuraLace、neurocare group AGなどが含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場の見通し ・世界の非侵襲的脳刺激装置市場規模：製品タイプ別 - 経頭蓋磁気刺激(TMS)装置の市場規模 - 経頭蓋電流刺激(TCS)装置の市場規模 ・世界の非侵襲的脳刺激装置市場規模：用途別 - うつ病における市場規模 - てんかんにおける市場規模 - パーキンソン病における市場規模 - 慢性疼痛における市場規模 - その他用途における市場規模 ・世界の非侵襲的脳刺激装置市場規模：エンドユーザー別 - 病院における市場規模 - 外来手術センターにおける市場規模 - 専門クリニックにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の非侵襲的脳刺激装置市場規模：地域別 - 北米の非侵襲的脳刺激装置市場規模 - ヨーロッパの非侵襲的脳刺激装置市場規模 - アジア太平洋の非侵襲的脳刺激装置市場規模 - 中南米の非侵襲的脳刺激装置市場規模 - 中東/アフリカの非侵襲的脳刺激装置市場規模 ・競争状況 |
Non-invasive Brain Stimulation System Market – Scope of Report
TMR’s report on the global non-invasive brain stimulation system market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global non-invasive brain stimulation system market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global non-invasive brain stimulation system market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the non-invasive brain stimulation system market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global non-invasive brain stimulation system market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global non-invasive brain stimulation system market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global non-invasive brain stimulation system market.
The report delves into the competitive landscape of the global non-invasive brain stimulation system market. Key players operating in the global non-invasive brain stimulation system market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global non-invasive brain stimulation system market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market non-invasive brain stimulation system.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Non-invasive Brain Stimulation System Market Forecast
4.4. Global Non-invasive Brain Stimulation System Market Outlook
5. Market Outlook
5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.2. Key product/Brand Analysis
5.3. Diseases Epidemiology
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Product Type
6.1. Introduction
6.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
6.3. Global Non-invasive Brain Stimulation System Market Forecast, by Product Type
6.3.1. Transcranial Magnetic Stimulation (TMS) System
6.3.2. Transcranial Current Stimulation (TCS) System
6.4. Global Non-invasive Brain Stimulation System Market Analysis, by Product Type
7. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Application
7.1. Introduction
7.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
7.3. Global Non-invasive Brain Stimulation System Market Forecast, by Application
7.3.1. Depression
7.3.2. Epilepsy
7.3.3. Parkinson’s Disease
7.3.4. Chronic Pain
7.3.5. Others
7.4. Global Non-invasive Brain Stimulation System Market Analysis, by Application
8. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
8.3. Global Non-invasive Brain Stimulation System Market Forecast, by End-user
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Specialty Clinics
8.3.4. Others
8.4. Global Non-invasive Brain Stimulation System Market Analysis, by End-user
9. Global Non-invasive Brain Stimulation System Market Analysis, by Region
9.1. Global Non-invasive Brain Stimulation System Market Analysis, by Region
9.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Region
9.3. Global Non-invasive Brain Stimulation System Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Non-invasive Brain Stimulation System Market Analysis
10.1. North America Non-invasive Brain Stimulation System Market Overview
10.2. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country
10.3. North America Non-invasive Brain Stimulation System Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
10.5. North America Non-invasive Brain Stimulation System Market Forecast, by Product Type
10.5.1. Transcranial Magnetic Stimulation (TMS) System
10.5.2. Transcranial Current Stimulation (TCS) System
10.6. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
10.7. North America Non-invasive Brain Stimulation System Market Forecast, by Application
10.7.1. Depression
10.7.2. Epilepsy
10.7.3. Parkinson’s Disease
10.7.4. Chronic Pain
10.7.5. Others
10.8. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
10.9. North America Non-invasive Brain Stimulation System Market Forecast, by End-user
10.9.1. Hospitals
10.9.2. Ambulatory Surgical Centers
10.9.3. Specialty Clinics
10.9.4. Others
11. Europe Non-invasive Brain Stimulation System Market Analysis
11.1. Europe Non-invasive Brain Stimulation System Market Overview
11.2. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Europe Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
11.3.1. Germany
11.3.2. U.K.
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
11.5. Europe Non-invasive Brain Stimulation System Market Forecast, by Product Type
11.5.1. Transcranial Magnetic Stimulation (TMS) System
11.5.2. Transcranial Current Stimulation (TCS) System
11.6. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
11.7. Europe Non-invasive Brain Stimulation System Market Forecast, by Application
11.7.1. Depression
11.7.2. Epilepsy
11.7.3. Parkinson’s Disease
11.7.4. Chronic Pain
11.7.5. Others
11.8. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
11.9. Europe Non-invasive Brain Stimulation System Market Forecast, by End-user
11.9.1. Hospitals
11.9.2. Ambulatory Surgical Centers
11.9.3. Specialty Clinics
11.9.4. Others
12. Asia Pacific Non-invasive Brain Stimulation System Market Analysis
12.1. Asia Pacific Non-invasive Brain Stimulation System Market Overview
12.2. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
12.3.1. China
12.3.2. India
12.3.3. Japan
12.3.4. Australia & New Zealand
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
12.5. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Product Type
12.5.1. Transcranial Magnetic Stimulation (TMS) System
12.5.2. Transcranial Current Stimulation (TCS) System
12.6. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
12.7. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Application
12.7.1. Depression
12.7.2. Epilepsy
12.7.3. Parkinson’s Disease
12.7.4. Chronic Pain
12.7.5. Others
12.8. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
12.9. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by End-user
12.9.1. Hospitals
12.9.2. Ambulatory Surgical Centers
12.9.3. Specialty Clinics
12.9.4. Others
13. Latin America Non-invasive Brain Stimulation System Market Analysis
13.1. Latin America Non-invasive Brain Stimulation System Market Overview
13.2. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Latin America Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
13.5. Latin America Non-invasive Brain Stimulation System Market Forecast, by Product Type
13.5.1. Transcranial Magnetic Stimulation (TMS) System
13.5.2. Transcranial Current Stimulation (TCS) System
13.6. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
13.7. Latin America Non-invasive Brain Stimulation System Market Forecast, by Application
13.7.1. Depression
13.7.2. Epilepsy
13.7.3. Parkinson’s Disease
13.7.4. Chronic Pain
13.7.5. Others
13.8. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
13.9. Latin America Non-invasive Brain Stimulation System Market Forecast, by End-user
13.9.1. Hospitals
13.9.2. Ambulatory Surgical Centers
13.9.3. Specialty Clinics
13.9.4. Others
14. Middle East & Africa Non-invasive Brain Stimulation System Market Analysis
14.1. Middle East & Africa Non-invasive Brain Stimulation System Market Overview
14.2. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country
14.3. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of Middle East & Africa
14.4. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
14.5. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Product Type
14.5.1. Transcranial Magnetic Stimulation (TMS) System
14.5.2. Transcranial Current Stimulation (TCS) System
14.6. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
14.7. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Application
14.7.1. Depression
14.7.2. Epilepsy
14.7.3. Parkinson’s Disease
14.7.4. Chronic Pain
14.7.5. Others
14.8. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
14.9. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by End-user
14.9.1. Hospitals
14.9.2. Ambulatory Surgical Centers
14.9.3. Specialty Clinics
14.9.4. Others
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Brainbox Ltd.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. BrainsWay
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. eNeura, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Strategic Overview
15.2.3.4. SWOT Analysis
15.2.4. Flow Neuroscience
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Strategic Overview
15.2.4.4. SWOT Analysis
15.2.5. Magnus Medical, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Magstim
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Strategic Overview
15.2.6.4. SWOT Analysis
15.2.7. MagVenture
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. NeoSync, Inc. (Wave Neuroscience, Inc.)
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Strategic Overview
15.2.8.4. SWOT Analysis
15.2.9. NeuraLace
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Strategic Overview
15.2.9.4. SWOT Analysis
15.2.10. neurocare group AG
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Strategic Overview
15.2.10.4. SWOT Analysis
15.2.11. NeuroMetrix
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Product Portfolio
15.2.11.3. Strategic Overview
15.2.11.4. SWOT Analysis
15.2.12. Neuronetics
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Product Portfolio
15.2.12.3. Strategic Overview
15.2.12.4. SWOT Analysis
15.2.13. Soterix Medical, Inc.
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Product Portfolio
15.2.13.3. Strategic Overview